Li-Fraumeni syndrome in a Malaysian kindred.

[1]  A. D. Van den Abbeele,et al.  F18-fluorodeoxyglucose-positron emission tomography/computed tomography screening in Li-Fraumeni syndrome. , 2008, JAMA.

[2]  H. Sugimura,et al.  Identification and characterization of a novel germ line p53 mutation in familial gastric cancer in the Japanese population. , 2007, Carcinogenesis.

[3]  M. Olivier,et al.  The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families. , 2007, Cancer letters.

[4]  J. Ku,et al.  A TP53-truncating germline mutation (E287X) in a family with characteristics of both hereditary diffuse gastric cancer and Li-Fraumeni syndrome , 2004, Journal of Human Genetics.

[5]  Adopted on March.  American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  C. Harris,et al.  The IARC TP53 database: New online mutation analysis and recommendations to users , 2002, Human mutation.

[7]  D. Evans,et al.  Cancer phenotype correlates with constitutional TP53 genotype in families with the Li–Fraumeni syndrome , 1998, Oncogene.

[8]  J. Fraumeni,et al.  Multiple primary cancers in families with Li-Fraumeni syndrome. , 1998, Journal of the National Cancer Institute.

[9]  Y. Bang,et al.  The first documentation of Li-Fraumeni syndrome in Korea. , 1995, Journal of Korean medical science.

[10]  R. Ueda,et al.  Predominantly tumor-limited expression of a mutant allele in a Japanese family carrying a germline p53 mutation. , 1994, Oncogene.

[11]  M. Stratton,et al.  Constitutional mutation in exon 8 of the p53 gene in a patient with multiple primary tumours: molecular and immunohistochemical findings. , 1993, Oncogene.

[12]  S. Friend,et al.  Recommendations on predictive testing for germ line p53 mutations among cancer-prone individuals. , 1992, Journal of the National Cancer Institute.

[13]  S. Friend,et al.  Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms. , 1992, The New England journal of medicine.

[14]  W. Blattner,et al.  Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li–Fraumeni syndrome , 1990, Nature.

[15]  L. Strong,et al.  Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. , 1990, Science.

[16]  W. Blattner,et al.  A cancer family syndrome in twenty-four kindreds. , 1988, Cancer research.

[17]  J. Stockman.  F18-Fluorodeoxyglucose–Positron Emission Tomography/Computed Tomography Screening in Li-Fraumeni Syndrome , 2009 .

[18]  A. Chompret.  The Li-Fraumeni syndrome. , 2002, Biochimie.

[19]  M. Hollstein,et al.  p53 and human cancer: the first ten thousand mutations. , 2000, Advances in cancer research.